The capacity challenge:

Slides:



Advertisements
Similar presentations
Allied Health Professionals with Special Interest. AHPwSI
Advertisements

Implementing NICE guidance
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Colon and Rectal Cancer Update
Detecting Cancer earlier in Tower Hamlets – The New Network Service Dr. Tania Anastasiadis Tower Hamlets GP Cancer Lead & GP Macmillan facilitator The.
ACR and SBI Statement Margarita Zuley, MD Associate Professor, Radiology Medical Director, Breast Imaging University of Pittsburgh.
The Effect of the National Bowel Cancer Awareness Campaign on Colorectal Workload and Cancer Detection Miss D Owais/ Miss S E Green Colorectal Unit University.
The Wall Street Analyst Forum’s 17 th Annual Analyst Conference.
Colorectal cancer: How do we approach health disparities? Marta L. Davila, MD, FASGE University of Texas MD Anderson Cancer Center.
Background The 2 week wait referral system was designed to expedite the referral of patients, suspected to have cancer, from Primary to Secondary care.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
A Colonscope is used to remove or biopsy polyps  Night Prep.
Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn’s disease or adenomas NICE CG March 2011.
ANDREW LATCHFORD BSc, MBBS, MD, FRCP CONSULTANT GASTROENTEROLOGIST
Department of General Practice Aarhus University Diagnostic delay in cancer in primary health care Before and after introducing urgent referrals for suspected.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Delivering improvements in diagnostic services 31st March 2010.
Colorectal Pathway North Bristol NHS Trust. Background Colorectal pathway introduced in 2006 Shorten patient pathway Straight to test Reduce routes into.
SETTING UP THE SERVICE BY LYNN TOBIN. HOW DID WE GET HERE? ABUNDENCE OF EVIDENCE PROVIDING JUSTIFICATION FOR BOWEL CANCER SCREENING.
LOWER URINARY TRACT SYMPTOM MANAGEMENT CLINIC Julia Taylor Nurse Consultant Salford Royal Hospital NHS Foundation Trust.
MARK COLEMAN MBChB FRCS (Gen Surg) MD hon FRCPSG Consultant Colorectal Surgeon
Flexible Sigmoidoscopy And Whole Colon Imaging In The Diagnosis Of Cancer In Patients With Colorectal Symptoms Peter O’Leary Journal Club 13/10/08.
CT Colonography vs Colonoscopy for the Detection of Advanced Neoplasia David H. Kim, M.D., Perry J. Pickhardt, M.D., Andrew J. Taylor, M.D., Winifred K.
The management of low-risk basal cell carcinomas in the community Implementing NICE guidance in general practice May 2010 NICE guidance on cancer services.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
Diagnostic Intervals in Breast, Colorectal, Lung, Pancreatic, Oesophageal and Gastric Cancers and : Database Study Richard D NealBangor.
Cancer Research UK Facilitator Programme: Working in partnership to improve cancer outcomes Marion O’Neill March 2017.
FIT Programme (Faecal Immunohistochemical Test)
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
Evaluation of CT Coronary Angiography (CTCA) and Cardiac Magnetic Resonance (CMR) in patients presenting with Acute Chest Pain (ACP) at A&E Background.
An Electronic 2 Week Wait Referral System for Colorectal Cancer
Background Hand injury is a common presentation at A&E in the UK
Greg Rubin,1 Nafees Din,2 Richard Neal,2 William Hamilton3
‘Piloting change’ report on the Multi Disciplinary Diagnostic centre
The Role of the Consultant Radiographer in Diagnostic Imaging Services in the United Kingdom and Barriers to their practice. Authors: Jack Williams and.
The DEPression in Visual Impairment Trial:
Cancer Diagnosis in the Acute Setting (CaDiAS)
Developing Primary Care
Brady A. F. 1, Taylor A2, Lachlan K. L. 3 1
Phone triage could remove a large proportion of young non-urgent endoscopy referrals from Irish endoscopy waiting lists B.Christopher, K.Altamimi, C.Egan,
Dr James Carlton, Medical Adviser
Volume 147, Issue 5, Pages e1 (November 2014)
Welcome to Wessex Strategic Clinical Networks Transformation Project Workshop 20/09/2018.
Mr Michael Thomas, Colorectal Cancer SSG, 27th June 2018
Consultant Respiratory Physician Professor of Primary Care Oncology
Volume 147, Issue 5, Pages e1 (November 2014)
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
The BAHNO Head & Neck Cancer Surveillance Audit 2018
Somerset, Wiltshire, Avon & Gloucestershire Cancer Alliance
Standard 3.1 Patient Navigation Process
Colorectal Cancer Cancer Alliance Work
Worcestershire Colorectal Cancer 2ww Pathway
The BAHNO Head & Neck Cancer Surveillance Audit 2018
The STAR-TREC Trial SIV Presentation
PACS Dr Erika Denton National Clinical Lead for Diagnostic Imaging & Consultant Radiologist, Norfolk & Norwich University Hospital Trust 20th April 2005.
Expected impact – direct referral to MRI
Indications: Complicated DD after 6/52
AINTREE UNIVERSITY HOSPITAL, HEALTHY BOWEL CLINIC: FUNCTIONAL BOWEL DYSFUNCTION CARE PATHWAY This ‘Pathway’ is an example used in the NICE medical technology.
FIT for symptomatic patients
28 Day Faster Diagnosis Standard
Lucy Smith – Head of Therapy, Chesterfield Royal Hospital
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway
Squamous cell carcinoma pathway update
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Suspected Gynaecological Cancer Recognition & Referral
NHS Long Term Plan: Rapid Diagnostic Centres (RDC) The SWAG Approach
SWAG Cancer Alliance Rapid Diagnostic Service proposals
Colorectal 2 week wait pathways and “Getting FIT”
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway Guidance for investigating colorectal symptoms in primary care including IDA , Faecal.
Faecal Immunochemistry Test - qFIT
Presentation transcript:

The utilisation of CT colonography in patients symptomatic for colorectal cancer The capacity challenge: Within Guy’s and St Thomas’ NHS Foundation Trust, colon cancer is one of the two most difficult areas in terms of delivering cancer targets New NICE guidelines published in June 2015 have broadened the inclusion criteria for urgent cancer referrals for patients who are symptomatic for colon cancer. This means an increased number of urgent ‘2 Week Wait’ referrals to the Trust. Background Colorectal cancer is the third most common cancer in the UK and the second most common cause of cancer death in the UK CRC has an annual incidence of approximately 40,000 new cases Less than 10% of patients referred to NHS outpatient clinics on suspicion of CRC are actually diagnosed with the disease Increasing demand for optical colonoscopy is placing a considerable pressure on workload for secondary care STUDY AIM: The TOHETI study aims to assess whether a change in the current diagnostic pathway, replacing optical colonoscopy with CT colonography as the first-line test for symptomatic patients, will increase early detection of colon cancer, improve outcomes and have cost-saving benefits. Study details The study will take place in the Colorectal and Gastroenterology Units at Guy’s and St Thomas’ NHS Foundation Trust. Patients taking part in the study will undergo either a CT Colonography or an Optical Colonoscopy examination, as per Guy’s and St. Thomas’ current standard of care. Referral to Optical Colonoscopy will be the first imaging test as per GSTT’s standard of care during Phase 1 Referral to CT Colonography will be the first imaging test as per GSTT’s standard of care during Phase 2 The study aims to recruit 246 patients in total (123 patients in each group). Target group is patients referred for change in bowel habit requiring large bowel investigation Improvements to the bowel prep service have also been introduced, following patient feedback on their experience. The Study pathway: Outcomes Expected impact Patient experience and satisfaction Increased patient experience for patients undergoing the CT colonography-based pathway Quality of care Increased quality of life associated with the proposed pathway Shift of optical colonoscopy capacity to diagnose high risk CRC patients Cost-effectiveness Decreased overall cost per patient Increased cost-effectiveness in the management of symptomatic CRC patients “It is well established in the literature that CT colonography has an equivalent diagnostic accuracy to optical colonoscopy in the detection of medium sized polyps and cancers in the large bowel. At present it is an under-utilitised resource in our trust. This study will offer improved access to CT colonography as a non-invasive first line test for patients with large bowel symptoms. The outcome of this study will then help facilitate discussions on a revised Colon Cancer pathway in our trust, which should be more cost effective, with improved patient experience, and reduced waiting times.” Nyree Griffin, Consultant Radiologist, Gastrointestinal Imaging; Chief Investigator, TOHETI Colon study CONTACT US: Project Manager: Ms Bharti Malhotra Ext. 89578 Bharti.Malhotra@kcl.ac.uk